• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有呼吸窘迫综合征的狒狒接受外源性表面活性剂治疗后的胸部X线检查过程

Chest radiographic course after exogenous surfactant therapy in baboons with respiratory distress syndrome.

作者信息

Shimada S, Raju T N, Vidyasagar D, Maeta H, Bhat R

机构信息

Department of Pediatrics, University of Illinois, Chicago 90680.

出版信息

Crit Care Med. 1990 Sep;18(9):969-73. doi: 10.1097/00003246-199009000-00013.

DOI:10.1097/00003246-199009000-00013
PMID:2394121
Abstract

Exogenous surfactant materials have been used under a variety of treatment protocols in cases of neonatal respiratory distress syndrome (RDS). To evaluate the differences in radiologic changes that follow either an early or late therapy with exogenous bovine surfactant, we reviewed 189 serially obtained chest radiographs from 48 premature baboons with RDS studied under different treatment regimen. Twenty-six animals were controls (100 chest films), and 22 received 100 mg/kg bovine surfactant instilled via the trachea in three study protocols (89 chest films). Surfactant was given within 10 min of birth in one group and at 2 h of age in the other. In 25/26 controls, radiologic evidence of severe RDS was seen by 2 h of age; these changes persisted in 15 animals at 24 h. By contrast, a rapid clearing of radiologic features of RDS was seen following surfactant instillation in all 22 (100%) animals within 4 h, but one (4.5%) of these 22 deteriorated at 9 h of age. Pulmonary interstitial emphysema (PIE) was seen in 9/26 (34.6%) and pneumothorax in 5/26 (19.2%) control animals, while 1/22 (4.5%) surfactant-treated animals developed PIE, and none had pneumothorax. The presence of a shunt via the patent ductus arteriosus did not affect radiographic findings in 20 animals studied by contrast injection. Therapy for patent ductus arteriosus (PDA) also had no substantial influence on the radiographic findings, or with regard to the pulmonary course. Radiographic clearing of RDS occurred approximately 18 to 20 h prior to the improvement in pulmonary compliance.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

在新生儿呼吸窘迫综合征(RDS)病例中,外源性表面活性物质已在多种治疗方案下使用。为了评估早期或晚期使用外源性牛肺表面活性剂治疗后放射学变化的差异,我们回顾了48只患有RDS的早产狒狒在不同治疗方案下连续获得的189张胸部X光片。26只动物为对照组(100张胸片),22只动物在三个研究方案中经气管注入100mg/kg牛肺表面活性剂(89张胸片)。一组在出生后10分钟内给予表面活性剂,另一组在出生2小时时给予。在25/26例对照组中,2小时龄时可见严重RDS的放射学证据;这些变化在24小时时在15只动物中持续存在。相比之下,在所有22只(100%)动物中,注入表面活性剂后4小时内RDS的放射学特征迅速消失,但这22只动物中有1只(4.5%)在9小时龄时病情恶化。9/26(34.6%)例对照动物出现肺间质气肿(PIE),5/26(19.2%)出现气胸,而1/22(4.5%)接受表面活性剂治疗的动物出现PIE,无气胸发生。通过对比剂注射研究的20只动物中,经动脉导管未闭的分流对影像学表现无影响。动脉导管未闭(PDA)的治疗对影像学表现或肺部病程也无实质性影响。RDS的放射学改善比肺顺应性改善提前约18至20小时出现。(摘要截短至250字)

相似文献

1
Chest radiographic course after exogenous surfactant therapy in baboons with respiratory distress syndrome.患有呼吸窘迫综合征的狒狒接受外源性表面活性剂治疗后的胸部X线检查过程
Crit Care Med. 1990 Sep;18(9):969-73. doi: 10.1097/00003246-199009000-00013.
2
Respiratory distress syndrome treated with human surfactant: radiographic findings.用人肺表面活性物质治疗的呼吸窘迫综合征:影像学表现
Radiology. 1985 Nov;157(2):329-34. doi: 10.1148/radiology.157.2.3840268.
3
Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.肺表面活性剂蛋白制剂治疗呼吸窘迫综合征的极早产儿动脉导管未闭血流动力学
J Perinatol. 2010 Oct;30(10):671-6. doi: 10.1038/jp.2010.21. Epub 2010 Mar 25.
4
Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
Pediatr Res. 1989 Dec;26(6):565-9. doi: 10.1203/00006450-198912000-00010.
5
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.早期使用表面活性剂并短暂通气与选择性使用表面活性剂及持续机械通气治疗患有或有呼吸窘迫综合征风险的早产儿的比较
Cochrane Database Syst Rev. 2004(3):CD003063. doi: 10.1002/14651858.CD003063.pub2.
6
Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.在患有呼吸窘迫综合征的早产儿中,使用单剂量重组牛肺表面活性剂进行通气后表面活性剂替代疗法:一项多中心、双盲、随机试验的最终分析及与类似试验的比较。表面活性剂-TA研究组
Pediatrics. 1990 Nov;86(5):753-64.
7
The significance of recurrent lung opacities in neonates on surfactant treatment for respiratory distress syndrome.
Pediatr Radiol. 2001 Feb;31(2):87-91. doi: 10.1007/s002470000377.
8
Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.对于患有呼吸窘迫综合征(RDS)或有RDS风险的早产儿,早期给予表面活性剂并进行短暂通气与选择性给予表面活性剂及持续机械通气的比较。
Cochrane Database Syst Rev. 2002(2):CD003063. doi: 10.1002/14651858.CD003063.
9
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.合成表面活性剂与人类表面活性剂治疗呼吸窘迫综合征的影像学表现
AJR Am J Roentgenol. 1991 Aug;157(2):371-4. doi: 10.2214/ajr.157.2.1853824.
10
Surfactant replacement in the management of the neonatal respiratory distress syndrome.表面活性剂替代疗法在新生儿呼吸窘迫综合征治疗中的应用
Eur J Respir Dis Suppl. 1987;153:242-8.

引用本文的文献

1
Bronchopulmonary dysplasia early changes leading to long-term consequences.支气管肺发育不良的早期变化导致长期后果。
Front Med (Lausanne). 2015 Feb 12;2:2. doi: 10.3389/fmed.2015.00002. eCollection 2015.
2
Chronic lung disease in the preterm infant. Lessons learned from animal models.早产儿慢性肺病。动物模型中获得的经验教训。
Am J Respir Cell Mol Biol. 2014 Feb;50(2):233-45. doi: 10.1165/rcmb.2013-0014TR.
3
Surfactant replacement therapy.表面活性剂替代疗法。
Thorax. 1996 Nov;51(11):1137-54. doi: 10.1136/thx.51.11.1137.